DST

Chr 6AR

dystonin

Also known as: BP240, BPA, BPAG1, CATX-15, CATX15, CMYO29, D6S1101, DMH

This gene encodes a member of the plakin protein family of adhesion junction plaque proteins. Multiple alternatively spliced transcript variants encoding distinct isoforms have been found for this gene, but the full-length nature of some variants has not been defined. It has been reported that some isoforms are expressed in neural and muscle tissue, anchoring neural intermediate filaments to the actin cytoskeleton, and some isoforms are expressed in epithelial tissue, anchoring keratin-containing intermediate filaments to hemidesmosomes. Consistent with the expression, mice defective for this gene show skin blistering and neurodegeneration. [provided by RefSeq, Mar 2010]

Primary Disease Associations & Inheritance

Congenital myopathy 29 with contracturesMIM #621510
Epidermolysis bullosa simplex 3, localized or generalized intermediate, with bp230 deficiencyMIM #615425
AR
Lethal congenital contracture syndrome 12MIM #621511
Neuropathy, hereditary sensory and autonomic, type VIMIM #614653
AR
4094
ClinVar variants
42
Pathogenic / LP
1.00
pLI score· haploinsufficient
6
Active trials
Clinical SummaryDST
Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 1.00). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
42 Pathogenic / Likely Pathogenic· 128 VUS of 4094 total submissions
💊
Clinical Trials
6 active or recruiting trials — potential therapeutic options may be available

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

LoF intolerant — likely haploinsufficient
LoF Constraint?LOEUF (Loss-of-function Observed/Expected Upper bound Fraction) is the upper bound of the 90% CI for LoF OE — the preferred gnomAD v4 metric. Lower = more intolerant to LoF. LOEUF < 0.35 = highly constrained.
0.18LOEUF
pLI 1.000
Z-score 13.32
OE 0.14 (0.100.18)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint?Missense Z-score: standard deviations fewer missense variants observed vs. expected. Z > 3.09 (p < 0.001) = gene does not tolerate missense variation. OE missense < 0.6 is also considered constrained.
2.22Z-score
OE missense 0.88 (0.840.91)
2223 obs / 2537.8 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios?Shaded band = 90% confidence interval. Vertical tick = point estimate. Grey threshold line = gnomAD constraint cutoff for that variant class.
LoF OE?Ratio of observed to expected LoF variants. Upper CI bound (LOEUF) ≤ 0.35 = strong LoF constraint signal.0.14 (0.100.18)
00.351.4
Missense OE?Ratio of observed to expected missense variants. OE ≤ 0.6 = fewer missense variants than expected by chance.0.88 (0.840.91)
00.61.4
Synonymous OE?Control metric — synonymous variants are largely neutral and expected near OE = 1.0. Significant deviation may indicate annotation issues.0.98
01.21.6
LoF obs/exp: 38 / 277.4Missense obs/exp: 2223 / 2537.8Syn Z: 0.43

ClinVar Variant Classifications

4094 submitted variants in ClinVar

Classification Summary

Pathogenic29
Likely Pathogenic13
VUS128
Likely Benign118
Benign4
29
Pathogenic
13
Likely Pathogenic
128
VUS
118
Likely Benign
4
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
13
0
16
0
29
Likely Pathogenic
11
0
2
0
13
VUS
0
101
13
14
128
Likely Benign
0
8
26
84
118
Benign
0
0
3
1
4
Total241096099292

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

DST · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Gene2Phenotype Curations

DST-related neuropathy, hereditary sensory and autonomic

limited
ARUndeterminedUncertain
Eye
G2P ↗

Gene2Phenotype curations · DECIPHER consortium patient cohort (public variants) · deciphergenomics.org

OMIM — Genotype-Phenotype Relationships

1 OMIM entry

DYSTONIN; DST
MIM #113810 · *

Congenital myopathy 29 with contractures

MIM #621510

Molecular basis of disorder known

Epidermolysis bullosa simplex 3, localized or generalized intermediate, with bp230 deficiency

MIM #615425

Molecular basis of disorder known

Autosomal recessive

Lethal congenital contracture syndrome 12

MIM #621511

Molecular basis of disorder known

Neuropathy, hereditary sensory and autonomic, type VI

MIM #614653

Molecular basis of disorder known

Autosomal recessive
Clinical Literature
Landmark / reviewRecent case evidence
Key Publications
Landmark & review papers · by relevance
PubMed
Delamanid Resistance: Update and Clinical Management.
Nguyen TVA et al.·Clin Infect Dis
2020Review
Autonomous hypercortisolism: definition and clinical implications.
Reimondo G et al.·Minerva Endocrinol
2019Review
Decision support tools in low back pain.
Coupé VMH et al.·Best Pract Res Clin Rheumatol
2016Review
Top 10 resultsSearch PubMed ↗

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

Intracranial AtherosclerosisCognitive ImpairmentCerebrovascular Event

Cognitive Decline and Underlying Mechanisms in Symptomatic Intracranial Artery Stenosis Patients: A Cohort Study

RECRUITING
NCT06336174Anhui Medical UniversityStarted 2022-11-01
Aspirin Tablet, Clopidogrel Bisulfate Tablets and AtorvastatinEndovascular therapy,Aspirin Tablet, Clopidogrel Bisulfate Tablets and Atorvastatin
Refractory CancerRelapsed Cancer

Individualized Treatments in Adults With Relapsed/Refractory Cancers

ACTIVE NOT RECRUITING
NCT06024603Phase NACase Comprehensive Cancer CenterStarted 2023-11-20
Drug Sensitivity Test (DST)
Asymptomatic Intracranial StenosisCognitive ImpairmentCerebrovascular Event

Cognitive Decline and Underlying Mechanisms in Asymptomatic Intracranial Artery Stenosis Patients

RECRUITING
NCT05504330Anhui Medical UniversityStarted 2022-08-15
Aspirin Tablet, Clopidogrel Bisulfate Tablets and Atorvastatin
Multidrug-resistant TuberculosisPulmonary TuberculosisTuberculosis

Novel Triple-dose Tuberculosis Retreatment Regimen

RECRUITING
NCT04260477Phase PHASE3Institute of Tropical Medicine, BelgiumStarted 2021-03-01
6EH³R³Z6EHRZ
Pre-diabetes

High Protein Diet on Transcriptomic, Metabolomics, Hepatic and Pancreatic Fat Anatomy and Physiology in Asian Indians With Pre-diabetes

NOT YET RECRUITING
NCT05925933Phase NADiabetes Foundation, IndiaStarted 2023-10-01
Intervention
Alzheimer DiseaseMild Cognitive Impairment Due to Alzheimer&#39;s Disease

Alzheimer's Disease Multinuclear Imaging Neuro-Enhanced Resolution (AD-MINER)

RECRUITING
NCT07089303Chinese PLA General HospitalStarted 2025-07-01